⚠️ Disclaimer

Semax is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Semax is being researched for brain applications. Antagonizes α-MSH at MC4/MC5 receptors while inhibiting enkephalin-degrading enzymes to elevate endogenous opioid peptides. Dramatically upregulates BDNF protein for neuronal survival and synaptogenes. Common dosages for this use range from 200-600 mcg daily 2-4 times daily.

Can Semax Help With Brain?

Semax (Synthetic ACTH(4-10) analog heptapeptide) is being researched for brain applications based on its mechanism as a Neuropeptide, nootropic, ACTH analog.

Antagonizes α-MSH at MC4/MC5 receptors while inhibiting enkephalin-degrading enzymes to elevate endogenous opioid peptides. Dramatically upregulates BDNF protein for neuronal survival and synaptogenesis. Modulates dopaminergic and serotonergic systems for neuroprotection and cognitive enhancement.

What Does the Research Show for Semax and Brain?

Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

The relevance to brain specifically comes from Semax's effects on BDNF elevation, neuroprotection, cognitive enhancement, stroke recovery, memory consolidation.

What Protocol Is Used for Brain?

For brain applications, the standard Semax protocol is 200-600 mcg daily administered 2-4 times daily via intranasal spray for 5-14 days; repeated cycles with washout.

Some researchers adjust dosing based on the specific brain application — see our Semax dosage guide for full protocol details.

Can Stacking Improve Brain Results?

Synergizes with Selank — Semax drives BDNF/neuroprotection while Selank provides GABAergic anxiolysis, covering complementary cognitive pathways.

What Side Effects Apply to Brain Use?

Nasal irritation (dryness, burning). Nasal cavity discoloration in ~10% of users. Possible increased blood glucose in diabetics. Overall mild adverse effects.

Side effects are generally consistent regardless of the specific application. See our Semax side effects guide for details.

Calculate Your Semax Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Semax.

Open Calculator →

Bottom Line: Semax for Brain

Semax shows preliminary research potential for brain. Standard protocols (200-600 mcg daily, 2-4 times daily, 5-14 days; repeated cycles with washout) apply.

Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.

Complete Guide

Semax: The Russian Nootropic Peptide

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research Semax, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Semax

Particle → Browse Semax

Limitless → Browse Semax

Frequently Asked Questions

What is Semax?

Semax (Synthetic ACTH(4-10) analog heptapeptide) is a Neuropeptide, nootropic, ACTH analog. Developed by Russian scientists in the 1980s as a synthetic ACTH fragment analog for neuroprotection in stroke and cognitive decline. It is researched for BDNF elevation, neuroprotection, cognitive enhancement, stroke recovery, memory consolidation.

What is the recommended Semax dosage?

Common dosages: 200-600 mcg daily administered 2-4 times daily via intranasal spray. Cycle length: 5-14 days; repeated cycles with washout. Half-life: not established. Use our peptide calculator for exact reconstitution math.

What are the side effects of Semax?

Nasal irritation (dryness, burning). Nasal cavity discoloration in ~10% of users. Possible increased blood glucose in diabetics. Overall mild adverse effects.

Is Semax safe?

Semax has shown a preliminary safety profile in research. Not FDA-approved. Licensed pharmaceutical in Russia. Available as research chemical in US. All research should follow appropriate safety protocols.